Antidepressants Linked to Two-Fold Increase in Risk of Suicide
Results of Antidepressant Medicine Study
After a systematic review of 70 clinical trials and over 18,000 patients, researchers determined that the risk for suicide and aggression is doubled with the users of antidepressant drugs than their counterparts who do not use them. Numerous brands of drugs were used in their study.
The authors suggest that the ill effects of these medicines are severely underreported in pharmaceutical studies.
There was no link to increased risk in adults, but in adolescents and children the risk for suicide, aggression, and akathisia were higher across the board. The study was not able to determine which brands of drugs were related to the higher risks.
The authors also found that discrepancies between clinical studies by pharmaceutical companies and what was actually published for public review was huge. Especially, since school-shootings have been linked to these medicines, and the perpetrators have been found not guilty due to “drug-induced” insanity.
Joanna Moncrieff, MD, a senior lecturer with the Division of Psychiatry at University College London, United Kingdom, said that doctors should prescribe these drugs with caution especially for children and adolescents.
Statistics about Mental Health Disorder
The following information was provided by the World health Organization (WHO):
- 350,000,000 people globally are affected by some sort of depression.
- The percentage of adolescents who have a depressive disorder by the age of 18.
- 50% of Americans with major depression who don't seek treatment.
- Treatment usually takes 10-18 weeks to go into effect. With antidepressants, doctors recommend giving it 4-6 weeks before the medicine starts to take effect.
RECENT MEDICAL MALPRACTICE RESULT
$10.9 MillionExpenses: $175,000.00 | Attorneys Fees: $3,200,000.00 | Net to Client: $4,029,762.00 (Purchase of a Lifetime Annuity)
RECENT VEHICLE RECALL RESULT
$30.2 MillionExpenses: $39,576.15 | Attorneys Fees: $10,060,980.00 | Net to Client: $20,121,960.57